Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3068% below fair value
$4.03+0.02 (+0.50%)
Close on Nov 13, 2026Market cap $196.17MP/E –Yield –
Nu Skin Enterprises gross margin
Gross margin is gross profit as a percentage of revenue.
Nu Skin Enterprises's gross margin for the twelve months ending Sep 30, 2026 was 67.8%. For fiscal 2025 it was 69.4%, against 68.2% the year before. The highest annual figure on record is 84.1% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 69.4% | +1.2 |
| FY2024 | Dec 31, 2024 | 68.2% | −0.7 |
| FY2023 | Dec 31, 2023 | 68.9% | −2.7 |
| FY2022 | Dec 31, 2022 | 71.7% | −3.3 |
| FY2021 | Dec 31, 2021 | 75.0% | +0.4 |
| FY2020 | Dec 31, 2020 | 74.5% | −1.5 |
| FY2019 | Dec 31, 2019 | 76.0% | −0.4 |
| FY2018 | Dec 31, 2018 | 76.3% | −1.6 |
| FY2017 | Dec 31, 2017 | 78.0% | +0.6 |
| FY2016 | Dec 31, 2016 | 77.3% | −0.9 |
| FY2015 | Dec 31, 2015 | 78.2% | −3.2 |
| FY2014 | Dec 31, 2014 | 81.4% | −2.7 |
| FY2013 | Dec 31, 2013 | 84.1% | +0.6 |
| FY2012 | Dec 31, 2012 | 83.4% | +2.2 |
| FY2011 | Dec 31, 2011 | 81.2% | −1.0 |
| FY2010 | Dec 31, 2010 | 82.3% | +0.6 |
| FY2009 | Dec 31, 2009 | 81.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 65.0% | −5.5 |
| Q2 FY2026 | Jun 30, 2026 | 68.2% | −0.6 |
| Q1 FY2026 | Mar 31, 2026 | 66.9% | −0.9 |
| Q4 FY2025 | Dec 31, 2025 | 70.7% | +8.1 |
| Q3 FY2025 | Sep 30, 2025 | 70.5% | +0.4 |
| Q2 FY2025 | Jun 30, 2025 | 68.8% | −1.1 |
| Q1 FY2025 | Mar 31, 2025 | 67.8% | −2.7 |
| Q4 FY2024 | Dec 31, 2024 | 62.7% | −9.5 |
| Q3 FY2024 | Sep 30, 2024 | 70.1% | +11.5 |
| Q2 FY2024 | Jun 30, 2024 | 70.0% | −2.9 |
| Q1 FY2024 | Mar 31, 2024 | 70.5% | −1.8 |
| Q4 FY2023 | Dec 31, 2023 | 72.1% | +0.4 |
| Q3 FY2023 | Sep 30, 2023 | 58.6% | −9.1 |
| Q2 FY2023 | Jun 30, 2023 | 72.9% | −0.7 |
| Q1 FY2023 | Mar 31, 2023 | 72.3% | −1.0 |
| Q4 FY2022 | Dec 31, 2022 | 71.7% | −2.5 |
| Q3 FY2022 | Sep 30, 2022 | 67.7% | −7.5 |
| Q2 FY2022 | Jun 30, 2022 | 73.6% | −2.0 |
| Q1 FY2022 | Mar 31, 2022 | 73.3% | −1.5 |
| Q4 FY2021 | Dec 31, 2021 | 74.2% | +0.2 |
| Q3 FY2021 | Sep 30, 2021 | 75.2% | +1.3 |
| Q2 FY2021 | Jun 30, 2021 | 75.6% | +0.7 |
| Q1 FY2021 | Mar 31, 2021 | 74.8% | −0.9 |
| Q4 FY2020 | Dec 31, 2020 | 74.0% | −1.9 |
| Q3 FY2020 | Sep 30, 2020 | 73.9% | −2.3 |
| Q2 FY2020 | Jun 30, 2020 | 74.8% | −0.5 |
| Q1 FY2020 | Mar 31, 2020 | 75.7% | −0.8 |
| Q4 FY2019 | Dec 31, 2019 | 75.9% | −0.4 |
| Q3 FY2019 | Sep 30, 2019 | 76.2% | −0.4 |
| Q2 FY2019 | Jun 30, 2019 | 75.3% | −0.8 |
| Q1 FY2019 | Mar 31, 2019 | 76.5% | +0.2 |
| Q4 FY2018 | Dec 31, 2018 | 76.3% | −1.4 |
| Q3 FY2018 | Sep 30, 2018 | 76.7% | −1.9 |
| Q2 FY2018 | Jun 30, 2018 | 76.1% | −1.8 |
| Q1 FY2018 | Mar 31, 2018 | 76.3% | −1.4 |
| Q4 FY2017 | Dec 31, 2017 | 77.7% | −1.9 |
| Q3 FY2017 | Sep 30, 2017 | 78.6% | – |
| Q2 FY2017 | Jun 30, 2017 | 77.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 77.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 79.6% | – |
See a number that looks wrong?